News for Healthier Living

Metformin and Ursodeoxycholic Acid Both Fail to Improve Long COVID Recovery in New Clinical Trial

A randomized clinical trial found that a two-week course of metformin or ursodeoxycholic acid (UDCA) did not meaningfully improve recovery from long COVID symptoms, despite earlier evidence suggesting metformin could lower long-term risk when taken during acute infection.

March 2, 2026


March 5 2026

March 4 2026

March 3 2026

March 2 2026

March 1 2026

February 28 2026

February 27 2026

February 26 2026

February 25 2026

February 24 2026

February 23 2026

February 22 2026

February 21 2026

February 20 2026